Certified by Founder Lodge
Venrock
United States - Palo Alto, CA
INVESTOR
1 Disclosed Funding Rounds $40,000,000
102 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Venrock partners with entrepreneurs who want to tackle big, hard problems that most think not possible. For more information, please visit www.venrock.com or follow the firm on Twitter at @Ve
| Company | Date | Round | Raised |
|---|---|---|---|
 Dgraph Labs |
July, 20 ,2022 | Seed | $6,000,000 |
 Decodable |
February, 24 ,2022 | Series A | $20,000,000 |
| Decodable |
February, 24 ,2022 | Series A | $20,000,000 |
 Quiq |
April, 12 ,2022 | Series C | $25,000,000 |
| Quiq |
April, 12 ,2022 | Series C | $25,000,000 |
 Zero Networks |
February, 22 ,2022 | Series A | $20,300,000 |
 ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
 Nightfall AI |
August, 10 ,2022 | Series B | $40,000,000 |
| Zero Networks |
February, 22 ,2022 | Series A | $20,300,000 |
 Astronomer |
March, 23 ,2022 | Series C | $213,000,000 |
 Airspeed |
May, 08 ,2023 | Unknown | $7,500,000 |
| Airspeed |
May, 08 ,2023 | Unknown | $7,500,000 |
| Astronomer |
March, 23 ,2022 | Series C | $213,000,000 |
| Dgraph Labs |
July, 20 ,2022 | Seed | $6,000,000 |
 Moment |
September, 18 ,2023 | Series A | $17,000,000 |
| Decodable |
February, 24 ,2022 | Series A | $20,000,000 |
| Decodable |
February, 24 ,2022 | Series A | $20,000,000 |
| Quiq |
April, 12 ,2022 | Series C | $25,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| Zero Networks |
February, 22 ,2022 | Series A | $20,300,000 |
| Zero Networks |
February, 22 ,2022 | Series A | $20,300,000 |
| Airspeed |
May, 08 ,2023 | Unknown | $7,500,000 |
 RefleXion Medical |
November, 17 ,2023 | Unknown | $105,000,000 |
| Astronomer |
March, 23 ,2022 | Series C | $213,000,000 |
| Airspeed |
May, 08 ,2023 | Unknown | $7,500,000 |
| Moment |
September, 18 ,2023 | Series A | $17,000,000 |
| Moment |
September, 18 ,2023 | Series A | $17,000,000 |
| Decodable |
February, 24 ,2022 | Series A | $20,000,000 |
| Decodable |
February, 24 ,2022 | Series A | $20,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
 Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
| Zero Networks |
February, 22 ,2022 | Series A | $20,300,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| RefleXion Medical |
November, 17 ,2023 | Unknown | $105,000,000 |
| RefleXion Medical |
November, 17 ,2023 | Unknown | $105,000,000 |
| Airspeed |
May, 08 ,2023 | Unknown | $7,500,000 |
| Airspeed |
May, 08 ,2023 | Unknown | $7,500,000 |
| Moment |
September, 18 ,2023 | Series A | $17,000,000 |
 Archetype AI |
April, 08 ,2024 | Seed | $13,000,000 |
| Decodable |
February, 24 ,2022 | Series A | $20,000,000 |
| Moment |
September, 18 ,2023 | Series A | $17,000,000 |
| Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
| Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| RefleXion Medical |
November, 17 ,2023 | Unknown | $105,000,000 |
 Tembo(US) |
July, 03 ,2024 | Series A | $14,000,000 |
| Airspeed |
May, 08 ,2023 | Unknown | $7,500,000 |
| RefleXion Medical |
November, 17 ,2023 | Unknown | $105,000,000 |
| Archetype AI |
April, 08 ,2024 | Seed | $13,000,000 |
| Archetype AI |
April, 08 ,2024 | Seed | $13,000,000 |
| Moment |
September, 18 ,2023 | Series A | $17,000,000 |
| Moment |
September, 18 ,2023 | Series A | $17,000,000 |
| Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
| Tembo(US) |
July, 03 ,2024 | Series A | $14,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
| Tembo(US) |
July, 03 ,2024 | Series A | $14,000,000 |
 Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| RefleXion Medical |
November, 17 ,2023 | Unknown | $105,000,000 |
| RefleXion Medical |
November, 17 ,2023 | Unknown | $105,000,000 |
| Archetype AI |
April, 08 ,2024 | Seed | $13,000,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| Moment |
September, 18 ,2023 | Series A | $17,000,000 |
| Archetype AI |
April, 08 ,2024 | Seed | $13,000,000 |
| Tembo(US) |
July, 03 ,2024 | Series A | $14,000,000 |
 Candid Therapeutics |
September, 10 ,2024 | Unknown | $370,000,000 |
| Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
| Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
 Metsera |
November, 14 ,2024 | Series B | $215,000,000 |
| RefleXion Medical |
November, 17 ,2023 | Unknown | $105,000,000 |
| Tembo(US) |
July, 03 ,2024 | Series A | $14,000,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
 GenLogs |
February, 06 ,2025 | Series A | $14,600,000 |
| Archetype AI |
April, 08 ,2024 | Seed | $13,000,000 |
| Archetype AI |
April, 08 ,2024 | Seed | $13,000,000 |
| Candid Therapeutics |
September, 10 ,2024 | Unknown | $370,000,000 |
| Tembo(US) |
July, 03 ,2024 | Series A | $14,000,000 |
| Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
 Adyton PBC |
May, 16 ,2025 | Unknown | $11,000,000 |
| Metsera |
November, 14 ,2024 | Series B | $215,000,000 |
| Tembo(US) |
July, 03 ,2024 | Series A | $14,000,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| GenLogs |
February, 06 ,2025 | Series A | $14,600,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| Archetype AI |
April, 08 ,2024 | Seed | $13,000,000 |
| Candid Therapeutics |
September, 10 ,2024 | Unknown | $370,000,000 |
| Tembo(US) |
July, 03 ,2024 | Series A | $14,000,000 |
| Metsera |
November, 14 ,2024 | Series B | $215,000,000 |
| Adyton PBC |
May, 16 ,2025 | Unknown | $11,000,000 |
| GenLogs |
February, 06 ,2025 | Series A | $14,600,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| Adyton PBC |
May, 16 ,2025 | Unknown | $11,000,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
 Collate |
July, 16 ,2025 | Series A | $10,000,000 |
| Candid Therapeutics |
September, 10 ,2024 | Unknown | $370,000,000 |
| Metsera |
November, 14 ,2024 | Series B | $215,000,000 |
| GenLogs |
February, 06 ,2025 | Series A | $14,600,000 |
| Adyton PBC |
May, 16 ,2025 | Unknown | $11,000,000 |
| Collate |
July, 16 ,2025 | Series A | $10,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Maro | $4,300,000 | (Jul 25, 2025)
STELLARIA 🌀 | $23,000,000 | (Jul 25, 2025)
Memories.ai | $8,000,000 | (Jul 25, 2025)
Flend | $3,000,000 | (Jul 25, 2025)
LegalOn Technologies | $50,000,000 | (Jul 25, 2025)
